IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
May 17, 2024 17:39 ET
|
IntelGenx Technologies Corp.
MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and...
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
May 17, 2024 10:04 ET
|
IntelGenx Technologies Corp.
MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “Company” or “IntelGenx”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and...
CryoMass Partners with Cannabis Powerhouse LEEF to Deploy Its Cryo Separation Technology
May 16, 2024 07:10 ET
|
Cryomass Technologies
CryoMass announced the sale of its second CryoSift Separator™ production model for US$1.2 million.
CryoMass Announces Sale of First Production Model to be deployed in Canada
May 14, 2024 07:10 ET
|
Cryomass Technologies
The transaction we are announcing today is the first of such Unit sales for CAD$1.62 million, which will be deployed in Canada.
IntelGenx Announces Voting Results on Election of Directors
May 08, 2024 07:45 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that, at the annual meeting of shareholders of...
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024
April 24, 2024 22:11 ET
|
Association québécoise des technologies (AQT)
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024Charlevoix (Québec), le 24 avril 2024 – C’est avec fierté que l’AQT
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
April 08, 2024 07:45 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Montelukast VersaFilm® has been administered to...
Bion Announces Voluntary Share Surrender
April 02, 2024 08:34 ET
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, April 02, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef,...
IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results
March 21, 2024 07:30 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and...
IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow
March 14, 2024 16:30 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 14, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release...